We are delighted to announce the following Sponsors
of the XXVII Biennial ISER Meeting 2026
and would like to thank all companies/foundations/institutes
for their support!
Platinum Sponsor
The Knights Templar Eye Foundation, Inc. supports innovative clinical and basic research aimed at preventing and treating potentially blinding eye diseases in infants and children. Funding is available for studies focused on conditions such as amblyopia, cataract, glaucoma, retinopathy of prematurity, retinoblastoma, and other hereditary or developmental eye disorders. The Foundation is dedicated to advancing discoveries that improve vision care and outcomes for children and adults alike. Please visit https://www.ktef.org for more information on current grants and funding opportunities.
Gold Sponsor
BrightFocus Foundation is a premier source of global research funding to defeat macular degeneration, glaucoma and Alzheimer’s & related dementias. We envision a world where we age free of diseases of mind and sight, supporting nearly 2,100 projects and 7,000 scientists since our inception—a more than $315 million investment. In addition, BrightFocus shares the latest research findings and expert information with the public, to empower families impacted by these diseases. Please visit https://www.brightfocus.org/about/for-scientists/ for more information on current grants and how to apply for future funding.
Bronze Sponsor
Founded in 2000, WestChina-Frontier is a premier GLP-compliant research organization specializing in non-clinical drug development and evaluation. The company holds multiple international and national accreditations, including NMPA GLP certification, U.S. FDA GLP inspections, OECD GLP certification, AAALAC accreditation, CAP certification, and CNAS accreditation. With over two decades of experience, WestChina-Frontier has established a standardized, internationally recognized, large-scale, and data-driven platform for non-clinical drug research. It serves as a key technical partner in new drug development and a leading innovation hub for drug evaluation technologies in China. WestChina-Frontier operates approximately 80,000 square meters of state-of-the-art, GLP-compliant laboratory facilities. The institution is supported by a team of over 1,000 skilled professionals and is equipped with cutting-edge analytical and testing instruments. It has implemented a Laboratory Information Management System (LIMS) aligned with global standards, enabling a high level of data integrity and operational efficiency. WestChina-Frontier provides a comprehensive portfolio of non-clinical services, including pharmacology, pharmacokinetics and toxicology studies for small molecules, biologics, vaccines, cell and gene therapies. Research capabilities cover a broad range of laboratory animal models, including rodents, rabbits, dogs, miniature pigs, and non-human primates. In addition, the company offers integrated bioanalytical services, including method development, along with immunogenicity assessments.
The National Foundation for Eye Research (NFER) is a nonprofit organization dedicated to the support and promotion of lens and cataract research. Our ultimate goal is the development of a nonsurgical treatment for cataracts. Many of our members have made lifelong commitments to this goal and are researchers renowned for their numerous contributions to this field.
We are a UK-based sight charity that funds pioneering research into the causes of eye disease, to develop preventative methods and more effective treatments for children and adults.
We invest in any and all eye conditions, whether common or rare, mild or severe, from age-related macular degeneration to glaucoma.
As of 2026, Sight Research UK has delivered 40 years of visionary science. We have transformed the landscape of eye care, putting patient-driven progress at the heart of everything we do.
